Oleic acid, a monounsaturated fatty acid, exhibits anti-proliferative and anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer

被引:0
|
作者
Newton, Meredith [1 ]
Suo, Hongyan [2 ]
Burkett, Wesley [1 ]
Zhao, Ziyi [1 ]
Zhou, Chunxiao [1 ]
Bae-Jump, Victoria [1 ]
机构
[1] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[2] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
261
引用
收藏
页码:S140 / S140
页数:1
相关论文
共 50 条
  • [1] Ascorbate exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer
    John, Catherine
    Shen, Xiaochang
    Deng, Boer
    Zhao, Ziyi
    Zhou, Chunxiao
    Bae-Jump, Victoria
    Secord, Angeles Alvarez
    Batinic-Haberle, Ines
    Spasojevic, Ivan
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 176 : S37 - S38
  • [2] Ipatasertib, an oral AKT inhibitor, exhibits anti-proliferative and anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium
    O'Donnell, Jillian
    Buckingham, Lindsey
    Hao, Tianran
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 162 : S41 - S42
  • [3] Palmitic acid, a common long-chain saturated fatty acid, demonstrates anti-proliferative and anti-tumorigenic effects in pre-clinical models of endometroid endometrial cancer
    Burkett, Wesley
    Zhao, Ziyi
    Newton, Meredith
    Zhou, Chunxiao
    Bae-Jump, Victoria
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S140 - S140
  • [4] Docosahexaenoic acid, an omega-3 fatty acid, exhibits anti-tumorigenic effects in endometrial cancer
    Pierce, S. R.
    West, L.
    Yin, Y.
    Fang, Z.
    Zhou, C.
    Bae-Jump, V. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 : 58 - 59
  • [5] Ipatasertib, an oral AKT inhibitor, in combination with paclitaxel exhibits anti-proliferative and anti-tumorigenic effects in preclinical studies for endometrioid endometrial cancer: Endometrial cancer molecularly targeted therapy consortium
    Newton, Meredith
    Burkett, Wesley
    Zhao, Ziyi
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S125 - S126
  • [6] Ipatasertib, an oral AKT inhibitor, in combination with Bevacizumab exhibits anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium
    Newton, Meredith
    Burkett, Wesley
    Zhao, Ziyi
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S31 - S31
  • [7] Sulindac exhibits anti-proliferative effects in pre-clinical models of ovarian cancer
    Sinha, Nikita
    Chen, Shuning
    Haag, Jennifer
    Shen, Xiaochang
    Deng, Boer
    Zhao, Ziyi
    Zhou, Chunxiao
    Bae-Jump, Victoria
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [8] Docosahexaenoic acid demonstrates anti-tumorigenic effects in endometrial cancer
    O'Donnell, Jillian A.
    Buckingham, Lindsey K.
    Pierce, Stuart R.
    West, Lindsay
    Yin, Yiajie
    Sun, Wenchuan
    Fang, Ziwei
    Lee, Douglas
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (02) : 395 - 396
  • [9] Docosahexaenoic acid demonstrates anti-tumorigenic effects in endometrial cancer.
    O'Donnell, Jillian A.
    Buckingham, Lindsey K.
    Pierce, Stuart R.
    West, Lindsay
    Yin, Yiajie
    Sun, Wenchuan
    Fang, Ziwei
    Lee, Douglas P.
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (03)
  • [10] Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer
    Deng, Boer
    Kong, Weimin
    Suo, Hongyan
    Shen, Xiaochang
    Newton, Meredith A.
    Burkett, Wesley C.
    Zhao, Ziyi
    John, Catherine
    Sun, Wenchuan
    Zhang, Xin
    Fan, Yali
    Hao, Tianran
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    [J]. CANCERS, 2023, 15 (22)